Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, “Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H2, 2013" provides data on the Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) 25
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Sanofi 34
Clinical Trial Overview of Sanofi 34
AstraZeneca PLC 35
Clinical Trial Overview of AstraZeneca PLC 35
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
Merck and Co., Inc. 37
Clinical Trial Overview of Merck and Co., Inc. 37
Utrecht Holdings 38
Clinical Trial Overview of Utrecht Holdings 38
Foxhollow Technologies, Inc. (Inactive) 39
Clinical Trial Overview of Foxhollow Technologies, Inc. (Inactive) 39
AnGes MG, Inc. 40
Clinical Trial Overview of AnGes MG, Inc. 40
Bracco Diagnostics Inc. 41
Clinical Trial Overview of Bracco Diagnostics Inc. 41
Bayer AG 42
Clinical Trial Overview of Bayer AG 42
ActivBiotics Canada, Inc. 43
Clinical Trial Overview of ActivBiotics Canada, Inc. 43
Clinical Trial Overview of Top Institutes / Government 44
National Heart, Lung, and Blood Institute 44
Clinical Trial Overview of National Heart, Lung, and Blood Institute 44
Medical University of Vienna 45
Clinical Trial Overview of Medical University of Vienna 45
Northwestern University 46
Clinical Trial Overview of Northwestern University 46
University Hospital, Angers 47
Clinical Trial Overview of University Hospital, Angers 47
Nagoya University 48
Clinical Trial Overview of Nagoya University 48
Duke University 49
Clinical Trial Overview of Duke University 49
University of Virginia 50
Clinical Trial Overview of University of Virginia 50
The University of Aberdeen 51
Clinical Trial Overview of The University of Aberdeen 51
Brigham and Women's Hospital 52
Clinical Trial Overview of Brigham and Women's Hospital 52
Academic Medical Centre 53
Clinical Trial Overview of Academic Medical Centre 53
Five Key Clinical Profiles 54
Appendix 98
Abbreviations 98
Definitions 98
Research Methodology 99
Secondary Research 99
About GlobalData 100
Contact Us 100
Disclaimer 100
Source 101



List of Tables

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 12
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 13
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, North America, Top Countries, 2013* 14
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 15
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 16
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, BRIC Countries, 2013* 17
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, G7 Countries, 2013* 18
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, E7 Countries, 2013* 20
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Phase, 2013* 22
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 23
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 34
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 35
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 36
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2013* 37
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Utrecht Holdings, 2013* 38
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Foxhollow Technologies, Inc. (Inactive), 2013* 39
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2013* 40
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bracco Diagnostics Inc., 2013* 41
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 42
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by ActivBiotics Canada, Inc., 2013* 43
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 44
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013* 45
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2013* 46
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Angers, 2013* 47
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya University, 2013* 48
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 49
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2013* 50
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Aberdeen, 2013* 51
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2013* 52
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2013* 53

List of Figures
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 12
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 13
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 14
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 15
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 16
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, BRIC Countries (%), 2013* 17
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, G7 Countries (%), 2013* 18
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, E7 Countries (%), 2013* 20
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 22
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 23
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33
GlobalData Methodology 99

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

  • $ 7 995
  • Industry report
  • June 2014
  • by Global Data

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018 Summary Chronic lymphocytic leukemia (CLL), the most common form of adult leukemia, is caused by the uncontrolled ...

Multiple Sclerosis (MS) Drugs and Biologics : Technologies and Global Markets

Multiple Sclerosis (MS) Drugs and Biologics : Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This BCC Research study offers an overview of the multiple sclerosis (MS) disease-modifying product market, including regulatory issues accompanied by detailed analyses and forecasts by product. Its main ...

Sleep Aids : Technologies and Global Markets

Sleep Aids : Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

Research on the working of the human brain in relation to sleep is a fairly new area, with many new and novel theories. The discovery of new mechanisms and chemicals in the brain has provided expanding ...

Bcc Research Bitopertin Forecast

August 2014 $ 5 500

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.